Spectrum Science, a leading player in the healthcare industry, has made another strategic acquisition in the world of clinical trial enrollment. The network announced on Thursday morning that it has acquired Continuum Clinical, a clinical trial enrollment company based just outside of Chicago. While the terms of the deal were not immediately disclosed, Spectrum Science purchased the firm from independent marketing agency Blue Chip Worldwide.
Continuum Clinical will join Spectrum’s existing clinical trial recruitment strategic pillar, and Neil Weisman will continue as president of the organization. CEO Jonathan Wilson hailed the acquisition as an opportunity for the agency to expand its presence in the patient recruitment space. With the backing of private equity firm Knox Lane, Spectrum Science continues to be an active player in the agency M&A arena.
This acquisition comes after Spectrum Science’s purchase of healthcare agencies CrowdPharm and Hot Iron Health a few months earlier. The combined company will be led by CrowdPharm MD and partner Mike Myers, who will serve as president and lead day-to-day operations. Continuum Clinical president Weisman expressed excitement over joining a partner that holds a compatible view of the future of patient recruitment.